Hilgo Bruining

Affiliations: 
Amsterdam UMC 
Google:
"Hilgo Bruining"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Diachenko M, Houtman SJ, Juarez-Martinez EL, et al. (2022) Improved Manual Annotation of EEG Signals through Convolutional Neural Network Guidance. Eneuro. 9
Juarez-Martinez EL, van Andel DM, Sprengers JJ, et al. (2022) Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study. Frontiers in Neuroscience. 16: 879451
van Andel DM, Sprengers JJ, Keijzer-Veen MG, et al. (2022) Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial. Frontiers in Psychiatry. 13: 780281
Geertjens L, van Voorst TW, Bouman A, et al. (2022) Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders. Genes. 13
Houtman SJ, Lammertse HCA, van Berkel AA, et al. (2021) Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG. Frontiers in Physiology. 12: 775172
Juarez-Martinez EL, Sprengers JJ, Cristian G, et al. (2021) Prediction of behavioral improvement through resting-state EEG and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
Bruining H, Hardstone R, Juarez-Martinez EL, et al. (2020) Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics. Scientific Reports. 10: 9195
Juarez Martinez EL, Bruining H, Sprengers J, et al. (2019) O-20 Epileptiform and non-epileptiform EEG abnormalities in Autism Spectrum Disorder relate to opposite excitation-inhibition balance disturbances Clinical Neurophysiology. 130: e27-e28
Marije van Andel D, Sprengers J, Juarez-Martinez E, et al. (2019) 222. Cognitive Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S92
Sprengers J, Oranje B, Marije van Andel D, et al. (2019) 221. Behavioural and Neurophysiological Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S91-S92
See more...